Stocky turns companies like Castle Biosciences, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Castle Biosciences, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 8 Aug 2026Quarterly earnings show how well the company is performing and whether it's growing.
Company disclosed earnings and business updates to investors on July 30, 2026.
Directors make key company decisions, so who shareholders elect matters for company direction.
Quarterly earnings show how well the company is performing and whether it's growing.
Company disclosed earnings and business updates to investors on May 6, 2026.
Annual earnings show total company performance for the entire year and long-term trends.
Company disclosed annual earnings and business updates to investors on February 26, 2026.
Stocky reads Castle Biosciences, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Castle Biosciences, Inc.'s most recent tracked filing was a 10-Q on 30 Jul 2026: Castle Biosciences reports second quarter 2026 results.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
This page is just a preview. Open the live, interactive version for the full picture:
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 8 Aug 2026.